论文部分内容阅读
目的 :探讨ⅠB和ⅡA期子宫颈癌治疗方法。方法 :分析 2 0 0 0年 2月～ 2 0 0 2年 1月浙江省肿瘤医院收治的 2 96例ⅠB和ⅡA期子宫颈癌病例。结果 :35岁以下子宫颈癌患者 4 8例 ,其腺癌比例及盆腔淋巴转移率高。所有患者术后病理未发现卵巢转移。 13例宫颈肿瘤≥ 4cm患者行新辅助化疗 ,均顺利手术切除。结论 :近年来 35岁以下患者子宫颈癌发病呈上升趋势。卵巢移位术是保留年轻妇女子宫颈癌患者卵巢功能的简便有效方法。对具有盆腔淋巴转移高危因素的患者选择新辅助化疗是合理的
Objective: To investigate the treatment of ⅠB and ⅡA cervical cancer. Methods: A total of 2 96 cervical cancer cases ⅠB and ⅡA were treated in Zhejiang Cancer Hospital from February 2000 to January 2002. Results: Forty-eight cervical cancer patients under 35 years old had high proportion of adenocarcinoma and pelvic lymphatic metastasis. All patients had no ovarian metastasis after surgery. Neoadjuvant chemotherapy was performed in 13 cases of cervical cancer ≥ 4 cm, which were successfully surgically removed. Conclusion: In recent years, the incidence of cervical cancer in patients under 35 years of age is on the rise. Ovarian transposition is a simple and effective method to preserve ovarian function in young women with cervical cancer. It is reasonable to choose neoadjuvant chemotherapy in patients with risk factors for pelvic lymphatic metastasis